TP53 and breast carcinoma: Contrary to Luminal A and B subtypes, sporadic Her2 breast cancer has a high prevalence of p53 mutations (72%) [1] that predict poor prognosis due to a more aggressive disease and increased susceptibility to metastatic recurrence [4].